Good morning :)
$
₹
I

InterCure Ltd.

INCR

NASDAQ
I

InterCure Ltd.

INCR

NASDAQ
$5.410.18% (-0.00)
$
₹
$5.410.18% (-0.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
Loading...
1D
1W
1M
1Y
5Y
Max

Healthcare

Drug Manufacturers - Specialty & Generic

Micro Cap

With a market cap of $81.3M the stock is ranked 4820

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

—
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

0.61
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$-1.09
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

—
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

-13.22%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Company Profile

InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

Peers

Peers

AbbVie Inc
ABBV
AbbVie Inc
P/E Ratio
72.44
72.44
1Y Return
23.12%
23.12%
Buy Reco %
57.14
57.14
Amgen Inc
AMGN
Amgen Inc
P/E Ratio
27.17
27.17
1Y Return
57.16%
57.16%
Buy Reco %
46.87
46.87
Gilead Sciences Inc
GILD
Gilead Sciences Inc
P/E Ratio
—
—
1Y Return
31.2%
31.2%
Buy Reco %
63.33
63.33
Vertex Pharmaceuticals Inc
VRTX
Vertex Pharmaceuticals Inc
P/E Ratio
31.84
31.84
1Y Return
33.81%
33.81%
Buy Reco %
52.94
52.94
Regeneron Pharmaceuticals Inc
REGN
Regeneron Pharmaceuticals Inc
P/E Ratio
20.49
20.49
1Y Return
45.28%
45.28%
Buy Reco %
76.00
76.00

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareDrug Manufacturers - Specialty & Generic

Valuation

Returns

Forecast

StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
InterCure Ltd. -0.61-
AbbVie Inc72.4450.450.37
Amgen Inc27.1720.542.13

Price Comparison

Price Comparison

1 Month

1 Year

5 Years

Loading...

Financials

Financials

Income

Balance Sheet

Cash Flow

65
-0.8
70
-17
70
-17
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Revenue
Net Income
Financial YearQ4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026
Total Revenue-62.8662.8656.55-656570.09-70.09
Net Income-0.710.71-34.61--0.85-0.85-17--17
Net Profit Margin-1.13%1.13%-61.20%--1.31%-1.31%-24.25%--24.25%
See CostsAll values in $ Million

Frequently asked questions

Frequently asked questions

  1. InterCure Ltd. (INCR) share price today is $5.41 as of September 9, 2026 at 1:30 AM IST. The stock touched a day high of $5.57 and a day low of $5.39.

  2. InterCure Ltd. stock trades on NASDAQ under the ticker symbol INCR.

  3. InterCure Ltd.'s market capitalization is $81.32M as of September 9, 2026 at 1:30 AM IST.

  4. InterCure Ltd.'s price-to-earnings (P/E) ratio is N/A as of September 8, 2026.

  5. InterCure Ltd.'s price-to-book (P/B) ratio is 0.61 as of September 8, 2026.

  6. Yes, You can buy InterCure Ltd. shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy InterCure Ltd. shares in three steps: 1. Search InterCure Ltd. on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since InterCure Ltd. trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in InterCure Ltd. (INCR) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 1.8484 shares at the current price of $5.41.

Loading...